跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,857 条关于
“P-GemOx”
全部
5,857
临床试验
1,283
药物
980
机构
79
资讯
3,515
去年
Sintilimab/Chidamide Combination Shows Promising Results in Early-Stage Natural Killer T-Cell Lymphoma
去年
Glofitamab-GemOx Shows Survival Benefit in Phase 3 STARGLO Trial for R/R DLBCL, But FDA Advisory Committee Questions US Applicability
3年前
Toripalimab, Lenvatinib, and GEMOX Combination Shows Promise in Advanced Intrahepatic Cholangiocarcinoma
9年前
Atezolizumab, Bevacizumab, and GEMOX Combination Shows Promise in Advanced Biliary Tract Cancer
3年前
Quanterix Launches Novel P-Tau 205 and P-Tau 212 Assays to Advance Alzheimer's Research
去年
Quanterix Launches First-to-Market p-Tau 205 and p-Tau 212 Assays for Alzheimer's Disease Research
去年
FDA Advisory Committee Discusses Columvi Combination for Relapsed or Refractory DLBCL
9个月前
Miltenyi's Dual-Target CAR-T Therapy Shows Superior Efficacy in Pivotal Trial for Relapsed Large B-Cell Lymphoma
2年前
Roche's Columvi Demonstrates 41% Reduction in Death Risk in Phase III DLBCL Trial
去年
FDA Accepts sBLA for Glofitamab Plus Chemotherapy in Relapsed/Refractory DLBCL
第 1 页,共 352 页
上一页
下一页